newsfilter
← Latest News
GlobeNewswire·

Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones

Cash runway anticipated to be extended from Q2 2025 to Q4 2025Data from multiple Phase 1 and 2 clinical trials expected in 2024 OXFORD, United Kingdom, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc